Back
Archrock Vs. Doximity Industry Stock Comparison
Buy
79
AROC
Archrock
Last Price:
24.21
Seasonality Move:
2.53%
Buy
72
DOCS
Doximity
Last Price:
58.08
Seasonality Move:
-1.56%
Buy
79
Archrock (AROC)
is a Buy
Is Archrock a Buy, Sell or Hold?
- The current Archrock [AROC] share price is $23.61. The Score for AROC is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- AROC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Doximity (DOCS)
is a Buy
Is Doximity a Buy, Sell or Hold?
- The current Doximity [DOCS] share price is $61.25. The Score for DOCS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- DOCS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AROC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 74.43 | Buy |
Chaikin Money Flow: | 1125021 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.07 - 21.99) | Buy |
Bollinger Bands (100): | (19.2 - 21.66) | Buy |
DOCS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.76 | Buy |
Relative Strength Index (14 RSI): | 88.77 | Buy |
Chaikin Money Flow: | 3535937 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.16 - 48.72) | Buy |
Bollinger Bands (100): | (28.75 - 43.25) | Buy |
AROC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.54 | Buy |
20-day SMA: | 20.96 | Buy |
50-day SMA: | 20.55 | Buy |
200-day SMA: | 19.7 | Buy |
8-day EMA: | 22 | Buy |
20-day EMA: | 21.27 | Buy |
50-day EMA: | 20.77 | Buy |
200-day EMA: | 19.14 | Buy |
DOCS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.64 | Buy |
20-day SMA: | 44.02 | Buy |
50-day SMA: | 41.92 | Buy |
200-day SMA: | 31.55 | Buy |
8-day EMA: | 49.3 | Buy |
20-day EMA: | 45.39 | Buy |
50-day EMA: | 41.86 | Buy |
200-day EMA: | 33.99 | Buy |
Archrock Earnings Growth & AROC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.34 per share.
Doximity Earnings Growth & DOCS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.25 per share.
Archrock Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Doximity Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |